Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.51 |
| ▸ | RAMP3 | O60896 | 14/20 | 0.49 |
| ▸ | CALCR | P30988 | 14/20 | 0.49 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.46 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.46 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.46 |
| ▸ | PLK1 | P53350 | 1/20 | 0.45 |
| ▸ | NPY4R | P50391 | 2/20 | 0.44 |
| ▸ | NPY1R | P25929 | 1/20 | 0.44 |
| ▸ | NPY2R | P49146 | 1/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29776766 | 0.89 | MAPK8 (0.58) | KEAP1RAMP3CALCRMAPK8MAPK9 | |
| SCHEMBL30443975 | 0.88 | ACE (0.45) | KEAP1RAMP3CALCRPLK1NPY4R | |
| SCHEMBL31481586 | 0.87 | OPRK1 (0.47) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30974082 | 0.87 | RAMP3 (0.55) | RAMP3CALCRMAPK8MAPK9MAPK10 | |
| SCHEMBL29651846 | 0.87 | KEAP1 (0.53) | KEAP1RAMP3CALCRMAPK8MAPK9 | |
| SCHEMBL29651851 | 0.87 | KEAP1 (0.53) | KEAP1RAMP3CALCRMAPK8MAPK9 | |
| SCHEMBL30817470 | 0.86 | KEAP1 (0.43) | KEAP1RAMP3CALCRNPY4RNPY1R | |
| SCHEMBL30974076 | 0.86 | ACE (0.47) | RAMP3CALCR | |
| SCHEMBL31419820 | 0.86 | NTSR2 (0.44) | PLK1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29466786 | 0.86 | MAPK8 (0.47) | RAMP3CALCRMAPK8MAPK9MAPK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025027181-A1 | AGENTS AND METHODS FOR TARGETED DELIVERY TO CELLS | BioNTech SE (DE) | 2025-02-06 | — | — | WO | disclosed |